tiprankstipranks
Trending News
More News >
Creightons plc (GB:CRL)
:CRL

Creightons (CRL) AI Stock Analysis

Compare
3 Followers

Top Page

GB

Creightons

(LSE:CRL)

52Neutral
Creightons faces significant financial challenges with declining revenues and negative net income, which heavily impact its overall score. Technical analysis also indicates bearish momentum. However, positive corporate events and strong cash flow performance provide some optimism. The valuation remains unattractive due to negative earnings. Overall, the stock score reflects the need for improved financial performance and strategic execution to enhance investor confidence.

Creightons (CRL) vs. S&P 500 (SPY)

Creightons Business Overview & Revenue Model

Company DescriptionCreightons PLC (CRL) is a UK-based company that specializes in the manufacturing and distribution of personal care and beauty products. The company operates across several sectors, including haircare, skincare, and fragrances. Creightons is known for its diverse range of high-quality products that cater to various consumer needs, with a focus on innovation and value for money. The company sells its products under several brand names and distributes them through multiple retail channels both domestically and internationally.
How the Company Makes MoneyCreightons makes money primarily through the sale of its personal care and beauty products. The company's revenue model is built around manufacturing its own brands as well as private label products for other retailers. Key revenue streams include sales from branded products, private label manufacturing, and international distribution. Creightons benefits from strong partnerships with major retailers, both in physical stores and online, which help in expanding its market reach and customer base. Additionally, the company invests in product innovation and marketing strategies to enhance brand visibility and drive sales growth.

Creightons Financial Statement Overview

Summary
Creightons faces challenges with declining revenues and negative net income, impacting its income statement. The balance sheet shows improved leverage but suffers from reduced equity and negative ROE. Cash flow performance remains strong, with positive operating and free cash flow, providing some financial stability. Continued focus on improving profitability and revenue growth is essential for future financial health.
Income Statement
45
Neutral
The company has experienced declining revenues, dropping from 61.2M in 2021 to 53.2M in 2024. Gross profit margin decreased from 39.7% in 2022 to 42.9% in 2024, indicating challenges in maintaining profitability. Net income turned negative in 2024, resulting in a net profit margin of -6.6%, highlighting significant profitability issues.
Balance Sheet
60
Neutral
The debt-to-equity ratio decreased from 0.32 in 2022 to 0.18 in 2024, indicating improved leverage. However, stockholder equity reduced to 22.1M in 2024. Return on equity turned negative at -16.0% in 2024, reflecting concerns over profitability. The equity ratio remained stable at 61.0% in 2024, showing a strong equity base.
Cash Flow
70
Positive
Operating cash flow was strong at 6.0M in 2024, and free cash flow improved to 5.4M in the same year. The operating cash flow to net income ratio is high, indicating good cash conversion despite a net income loss. Free cash flow growth showed resilience, with an increase from 4.7M in 2023 to 5.4M in 2024.
Breakdown
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
53.19M58.57M61.16M61.60M47.81M
Gross Profit
22.83M24.05M25.75M24.48M19.63M
EBIT
1.54M1.49M5.32M5.39M3.75M
EBITDA
-1.21M2.69M5.34M6.94M5.13M
Net Income Common Stockholders
-3.53M514.00K3.11M4.33M3.17M
Balance SheetCash, Cash Equivalents and Short-Term Investments
3.14M1.65M840.00K6.56M3.67M
Total Assets
36.14M45.54M47.85M33.55M28.31M
Total Debt
3.92M7.28M8.22M3.96M4.70M
Net Debt
781.00K5.63M7.38M-2.60M1.03M
Total Liabilities
14.09M20.06M22.17M13.46M12.74M
Stockholders Equity
22.05M25.48M25.68M20.09M15.57M
Cash FlowFree Cash Flow
5.42M4.67M-508.00K4.17M805.00K
Operating Cash Flow
6.03M5.81M1.22M5.41M6.54M
Investing Cash Flow
-608.00K-2.64M-8.09M-1.07M-5.49M
Financing Cash Flow
-3.95M-2.35M1.16M-1.46M2.25M

Creightons Technical Analysis

Technical Analysis Sentiment
Negative
Last Price25.50
Price Trends
50DMA
30.31
Negative
100DMA
31.81
Negative
200DMA
29.52
Negative
Market Momentum
MACD
-0.84
Negative
RSI
45.25
Neutral
STOCH
54.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CRL, the sentiment is Negative. The current price of 25.5 is below the 20-day moving average (MA) of 27.93, below the 50-day MA of 30.31, and below the 200-day MA of 29.52, indicating a bearish trend. The MACD of -0.84 indicates Negative momentum. The RSI at 45.25 is Neutral, neither overbought nor oversold. The STOCH value of 54.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:CRL.

Creightons Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
GBABF
82
Outperform
£13.98B10.0213.06%3.35%1.64%44.38%
81
Outperform
£117.64B24.0630.27%3.15%-0.76%-12.83%
GBRCH
67
Neutral
£214.69M4.018.15%10.76%-5.28%148.54%
66
Neutral
£68.07B22.695.92%7.72%-5.19%
62
Neutral
$19.87B13.65-16.14%3.29%1.16%3.90%
GBCRL
52
Neutral
£17.45M-10.61%1.76%-6.61%-319.08%
GBPZC
52
Neutral
£311.31M-2.48%4.84%-16.16%80.50%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CRL
Creightons
26.60
2.03
8.26%
GB:ULVR
Unilever
4,584.00
886.27
23.97%
GB:PZC
PZ Cussons
72.80
-10.07
-12.15%
GB:BATS
British American Tobacco
3,140.00
1,008.91
47.34%
GB:ABF
Associated British Foods
1,958.50
-369.68
-15.88%
GB:RCH
Reach plc
68.70
1.87
2.80%

Creightons Corporate Events

Other
Creightons Director Acquires Significant Shareholding
Positive
Apr 2, 2025

Creightons plc announced that Paul Watts, a Non-Executive Director, has acquired 107,000 ordinary shares at a price of £0.295 each. This transaction highlights the confidence of the company’s leadership in its market position and potential growth, which could positively impact stakeholder perceptions.

Delistings and Listing Changes
Creightons Joins AIM Market, Enhancing Investor Access
Positive
Mar 31, 2025

Creightons has announced the admission of its entire issued share capital to trading on AIM, a market operated by the London Stock Exchange. This move marks a significant shift from the Main Market’s Equity Shares category and is expected to enhance the company’s visibility and accessibility to investors.

Executive/Board Changes
Creightons Appoints Jemima Bird as Independent Non-Executive Director
Positive
Mar 25, 2025

Creightons plc has announced the appointment of Mrs. Jemima Bird as an Independent Non-Executive Director, effective from March 31, 2025. Mrs. Bird, who will also chair the Remuneration Committee, brings extensive experience from her roles in various companies, which is expected to contribute significantly to Creightons’ board and future development.

Other
Creightons Announces Director Share Transfer
Neutral
Mar 20, 2025

Creightons plc announced a shareholding transaction involving Paul Forster, a Non-Executive Director, who transferred 200,000 ordinary shares to his wife, Clare Forster. This transaction, which was conducted outside a trading venue, does not alter Mr. Forster’s beneficial holding, which remains at 951,318 shares, representing 1.4% of the company’s issued share capital.

Delistings and Listing ChangesShareholder MeetingsBusiness Operations and Strategy
Creightons PLC to Transition Shares from Main Market to AIM
Neutral
Mar 3, 2025

Creightons PLC, a company involved in the beauty and personal care industry, has announced the results of its General Meeting where shareholders approved a resolution to delist its ordinary shares from the Main Market of the London Stock Exchange and move them to AIM. This strategic shift is expected to take effect on March 31, 2025, and is aimed at potentially enhancing the company’s market positioning and operational flexibility. The decision reflects a significant change in the company’s trading platform, which could have implications for its stakeholders.

Delistings and Listing ChangesBusiness Operations and Strategy
Creightons PLC Plans Move to AIM Market for Strategic Benefits
Positive
Feb 6, 2025

Creightons PLC has announced its intention to transition its Ordinary Shares from the London Stock Exchange’s main market to AIM, an internationally recognized market operated by the London Stock Exchange and designed for smaller companies. The move aims to reduce costs and regulatory burdens, as AIM offers a more flexible regulatory regime better suited to the company’s size, enhancing shareholder value and allowing management to focus more on strategic objectives.

Executive/Board Changes
Creightons plc Appoints Paul Watts as Independent Non-Executive Director
Neutral
Jan 29, 2025

Creightons plc has announced the appointment of Mr. Paul Watts as an Independent Non-Executive Director, effective immediately. With over 40 years of experience in financial services, particularly in capital markets and audit assurance for listed companies, Watts is expected to bring valuable expertise to the board and serve as Chair of the Audit and Risk Committee, potentially strengthening the company’s governance and strategic direction.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.